XWU-93565-16800
6 vaccinations
8 coded responses
69 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 462 / IN
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-30
-
2021-04-06
Survey response — 21 day, dose 1MedDRA: Diarrhoea — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
-
2021-05-14
Survey response — 35 day, dose 2MedDRA: Diarrhoea — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-21
- 2021-07-09
- 2021-10-08
-
2021-11-07
Dose 3 — Pfizer-BioNTech
-
2021-11-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-14
-
2021-11-21
Survey response — 14 day, dose 3MedDRA: Chills, Migraine, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
-
2022-02-08
Survey response — 3 month, dose 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea, Sinus disorder, Sneezing — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2022-05-10
-
2022-05-14
Dose 4 — Pfizer-BioNTech
- 2022-05-14
-
2022-05-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-05-16
- 2022-05-17
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-21
- 2022-05-28
- 2022-06-04
-
2022-06-11
Survey response — 28 day, dose 4MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-06-11
Report sent to call center — 28 day, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-13
Call successfulParticipant prefers to complete VAERS report online
- 2022-06-18
- 2022-06-26
- 2022-08-13
-
2022-10-14
Dose 5 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
-
2022-10-18
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy, Pain in jaw — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolMedDRA releases: 2024-11 · check-in answers available
-
2022-10-19
Survey response — days 1–6 daily, dose 5MedDRA: Migraine, Salivary gland disorder — Feeling: Good · Headache · Be unable to work or attend schoolMedDRA releases: 2024-11 · check-in answers available
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-18
-
2022-11-25
Survey response — 42 day, dose 5MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
- 2023-01-13
- 2023-04-14
-
2023-04-22
Dose 6 — Pfizer-BioNTech
- 2023-05-08
- 2023-05-13
- 2023-05-20
- 2023-05-28
- 2023-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-11-07 | Pfizer-BioNTech | No |
| 4 | 2022-05-14 | Pfizer-BioNTech | No |
| 5 | 2022-10-14 | Pfizer-BioNTech | No |
| 6 | 2023-04-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-11 | Successful 2022-06-13 |
Participant prefers to complete VAERS report online |
Free text
Release 7
Symptoms: diarrhea
Release 8
Symptoms: Loose stools but may be diet related and not from vaccine.
Release 10
Symptoms: Low grade fever, chills, migraines congestion
Release 11
Symptoms: Cold and sinus, sneezing, runny nose, loose cough
Release 12
Symptoms: Unexplainable rash over whole body.
Systemic reaction (other): Swollen lymph nodes, jaw pain. Might be due to ear infection.
Systemic reaction (other): woke up with migraine; symptoms from yesterday reported (possible ear infection) turned out to be issue with salivary gland - likely not vaccine related.
Symptoms: Runny nose. Cold symptoms.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Pain in jaw | · | · | ✓ |
| SRO | Salivary gland disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release